





At Cancer Expert Now, we believe that the quick adaptation of the latest data and treatment evidence into practice is one of the most important factors in successful outcomes.
For patients
this means understanding your diagnosis and treatment options to the fullest. Talking to an expert oncologist gives you the information you need to have the right conversations with your treating oncologist and, ultimately, make confident treatment choices.
For oncologists
around the world, we expand on the journal articles, conferences and lectures you attend by providing a direct communication channel to leading academics and researchers so you can discuss the application of new data and treatment protocols to actual patient cases.

Cancer Expert Now's respected cancer experts focus on one specific cancer or
treatment type. They are up-to-date with the latest research
and treatments specific to your exact diagnosis.
Get to know some of our distinguished experts.
Paul Bunn, MD
University of Colorado
- Helped set the standards for the treatment and diagnosis of lung cancer
- Chaired the FDA Oncology Drug Advisory Committee
- Listed in Marquis' Who's Who in America














Janice Dutcher, MD
Cancer Research Foundation of New York
- Past-Chair of the FDA Oncology Drug Evaluation Committee
- Co-Chair of the National Cancer Institute Renal Cancer Task Force
- Listed in Marquis’ Who’s Who as well as Checkbook’s “Top Docs”
Mitchell Posner, MD
The University of Chicago Medicine
- Current Chairman of the Gastrointestinal Committee of the American College of Surgeons Oncology
- Group and Past President of the Society for Surgical Oncology
- Has published more than 200 articles, abstracts, and book chapters discussing his areas of specialty















Kenneth Tanabe, MD
Massachusetts General Hospital
- Research supported by the National Institutes of Health—continuously—for the past 23 years
- Developer of several engineered viruses that effectively destroy liver tumors
- First in identifying and demonstrating several crucial clinical breakthroughs
E. David Crawford, MD
University of Colorado School of Medicine
- Internationally recognized expert in urologic cancers
- Author or coauthor of over 600 scientific articles, 7 textbooks, and more than 50 book chapters
- Rated one of the top 20 urologists in the United States, for men, by Men’s Health Magazine





















Sagar Lonial, MD, FACP
Winship Cancer Institute
- Winner of numerous awards in his field and author of more than 200 scientific articles
- Serves on the editorial boards of the Journal of Clinical Oncology and Leukemia
- Myeloma Editor for Clinical Lymphoma, Myeloma, and Leukemia
I. Craig Henderson, MD
UCSF Helen Diller Family Comprehensive Cancer Center
- Served as PI of the pivotal trial on the importance of Paclitaxel (PTX) for early breast cancer
- Past Chairperson of the Oncologic Drugs Advisory Committee, FDA
- Recently wrote an essential single-author textbook about breast cancer





















Hope Rugo, MD
UCSF Helen Diller Family Comprehensive Cancer Center
- 2010 recipient of the Cancer Care Physician of the Year Award
- Recipient of the prestigious Susan G. Komen Promise Award
- Serves as an investigator and as a member of steering committees for several important national and international trials
William John Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center
- Program Director of the Hematology Oncology Fellowship Training Program at Northwestern
- Founding Editor-in-Chief of NEJM Journal Watch Hematology/Oncology
- Chair of the Breast Cancer Working Group/Moonshot 2020





















Henry Friedman, MD
The Preston Robert Tisch Brain Tumor Center
- Author of more than 500 peer-reviewed articles, reviews, and book chapters
- Senior Editor of CNS Oncology
- Recognized with many important awards, including the Visionary Award from the Tug McGraw Foundation
Alan Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center
- International leader in gastrointestinal cancers
- Member of the National Cancer Institute Colorectal taskforce
- Listed in Castle Connolly’s “America’s Top Doctors”





















Patrick Wen, MD
Dana Farber Cancer Institute, Harvard University
- Internationally renowned neurologist
- Co-Director of the National Cancer Institute-supported Adult Brain Tumor Consortium
- Listed in Castle Connolly’s “America’s Top Doctors
William Wood, MD
Emory University
- Globally recognized for his contributions to breast cancer therapy
- First Academic Dean of the Pan-African Academy of Christian Surgeons (PAACS)
- Editor-in-Chief of the renowned peer-review journal Oncology





















Robert Ozols, MD
Fox Chase Cancer Center
- Established the worldwide standard regimen for patients with ovarian cancer
- Internationally recognized leader in ovarian cancer and chemotherapy research
- Former member of FDA Oncology Drug Advisory Committee
Charles Balch, MD, PhD (hc)
MD Anderson Cancer Center
- Global authority for melanoma and breast cancer
- One of the first doctors to identify prognostic factors for Stage I, II, and III melanoma
- Helped establish the current standard for melanoma surgery





















Peter Wiernik, MD
St. Luke’s Roosevelt and Beth Israel Medical Centers
- Founder of the Comprehensive Cancer Center at Our Lady of Mercy Medical Center in NY
- Leader in hematology research
- Listed in Marquis’ Who’s Who
Our panel of experts is constantly growing to include more world-class experts. Criteria for the panel is rigorous and includes:
- Involved in clinical research
- Currently treating or recently retired
- Leadership roles within their institution
- Contributes to the oncology community through:
- Leadership in congresses
- Advisors to government agencies and committees
- Recognized by peers as a "thought leader" or influencer in their expertise
talking with a Cancer Expert